Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02578888 · ClinicalTrials.gov registry record · NA
Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies
A NA study, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
NCT02578888 is a NA study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 95 participants.
The verdict
NCT02578888, a NA study, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
Study Summary
This randomized clinical trial studies a palliative care program in improving the quality of life of patients with high-risk gynecologic malignancies that is original or first tumor in the body (primary) or has come back (recurrent). Palliative care is care given to patients and their families facing the problems associated with life-threatening illness, through the prevention and relief of suffering by means of early identification and impeccable assessment and treatment of pain and other problems, physical, psychosocial and spiritual. Studying a palliative care program may help doctors learn more about patients quality of life, use of healthcare services, and the relief of pain.
Interventions
- OTHER Palliative Therapy
- OTHER Palliative Therapy + idiographic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2015-04 |
| Est. Completion | 2019-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02578888
The ClinicalTrials.gov registry entry for NCT02578888 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Palliative Therapy is the first listed.
NCT02578888 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02578888 about?
NCT02578888 is a clinical study titled "Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies". This randomized clinical trial studies a palliative care program in improving the quality of life of patients with high-risk gynecologic malignancies that is original or first tumor in the body (primary) or has come back (recurrent). Palliative care is care given to patients and their families facin...
What is the current status of trial NCT02578888?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2015-04. Estimated completion is 2019-04.
What interventions are being tested in trial NCT02578888?
The interventions under investigation include: Palliative Therapy (OTHER), Palliative Therapy + idiographic (OTHER).
Who is sponsoring clinical trial NCT02578888?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.